Prurigo Nodularis: Emerging Evidence on Disease Pathophysiology and Treatment

Prurigo Nodularis: Emerging Evidence on Disease Pathophysiology and Treatment Co-Chairs, Sarah S. Chisolm, MD, and Brian S. Kim, MD, MTR, discuss prurigo nodularis in this CME activity titled “Taking a New Look at Prurigo Nodularis: How Is Emerging Evidence Regarding Disease Pathophysiology and Treatment Influencing Patient Care?.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZXX865. CME credit will be available until September 30, 2023.

• #education
• #cme
• #meded
• #dermatology
• #prurigo_nodularis
• #pruritis
• #dupilumab
• #nemolizumab
• #abrocitinib
• #vixarelimab
• #nambuphine
• #sarah_s_chisolm_md
• #brian_s_kim
• #md
• #mtr